Genome&Company Logo

Genome&Company

Develops microbiome drugs and novel immune checkpoint inhibitors for immuno-oncology.

314130 | KO

Overview

Corporate Details

ISIN(s):
KR7314130006
LEI:
Country:
South Korea
Address:
경기도 수원시 영통구 창룡대로256번길 50 7층, 8층, 수원시

Description

Genome&Company is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutics. The company's research and development pipeline is centered on two primary platforms: microbiome-based pharmaceuticals and novel immune checkpoint inhibitors for immuno-oncology. Its drug candidates are derived from its proprietary microbiome platform and are aimed at treating a range of diseases, with a significant focus on cancer. In addition to its pharmaceutical programs, the company develops and markets consumer healthcare products, including dietary supplements and cosmeceuticals, leveraging its expertise in microbes and probiotics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2019-05-30 00:00
주주총회소집공고
Korean 62.7 KB
2019-05-22 00:00
기타주요경영사항(자율공시)(상환전환우선주의 보통주 전환)
Korean 6.9 KB
2019-05-03 00:00
주주총회소집결의
Korean 12.1 KB
2019-05-03 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2019-04-25 00:00
기업설명회(IR)개최결과
Korean 7.2 KB
2019-04-16 00:00
기업설명회(IR)개최결과
Korean 7.3 KB
2019-04-15 00:00
기업설명회(IR)개최
Korean 7.7 KB
2019-04-15 00:00
기업설명회(IR)개최
Korean 7.7 KB
2019-04-01 00:00
사업보고서 (2018.12)
Korean 243.3 KB
2019-03-28 00:00
주식매수선택권부여에관한신고
Korean 20.0 KB
2019-03-26 00:00
정기주주총회결과
Korean 27.2 KB
2019-03-19 00:00
주식등의대량보유상황보고서(일반)
Korean 78.2 KB
2019-03-18 00:00
감사보고서제출
Korean 10.3 KB
2019-03-11 00:00
주주총회소집공고
Korean 100.8 KB
2019-03-07 00:00
주식등의대량보유상황보고서(일반)
Korean 102.1 KB

Automate Your Workflow. Get a real-time feed of all Genome&Company filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genome&Company

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genome&Company via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.